| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC3384 | Mk-0493 | Novel potent, orally active and selective agonist of the melanocortin receptor 4 (MC4R) |
|
| DCC3385 | mk-0499 | The class III antiarrhythmic agent, blocking HERG, a human cardiac delayed rectifier K+ channel |
|
| DCC3386 | Mk-0626 | Novel Dipeptidyl peptidase IV (DPP-4) inhibitor, improving neovascularization by increasing both the number of circulating endothelial progenitor cells and endothelial nitric oxide synthetase expression |
|
| DCC3387 | Mk-0633 Tosylate | Potent and Selective 5-Lipoxygenase Inhibitor |
|
| DCC3388 | Mk-0736 | Selective 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) inhibitor |
|
| DCC3389 | Mk-0916 | Selective 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) inhibitor |
|
| DCC3390 | Mk-1220 | Novel Macrocyclic Inhibitor of Hepatitis C Virus NS3/4A Protease with Improved Preclinical Plasma Exposure |
|
| DCC3391 | Mk-1597 | Novel renin inhibitor |
|
| DCC3392 | Mk-2295 | Potent TRPV1 antagonist |
|
| DCC3393 | Mk-386 | Potent and selective human type-1 5alpha-reductase inhibitor |
|
| DCC3394 | Mk-4541 | Novel Selective Androgen Receptor Modulator (SARM) |
|
| DCC3395 | Mk-5046 | Novel nonpeptide bombesin receptor subtype-3 agonist |
|
| DCC3396 | Mk-6884 | Novel potent muscarinic acetylcholine receptor 4 (M4) positive allosteric modulator (PAM) |
|
| DCC3397 | Mk-7725 | Novel bombesin receptor subtype-3 (BRS-3) modulator |
|
| DCC3398 | Mk-8245 Analog | Novel liver-targeting inhibitor of stearoyl-CoA desaturase (SCD) |
|
| DCC3399 | Mk-8666 Tromethamine | Novel agonist of G-protein coupled receptor 40 (GPR40) |
|
| DCC3400 | Mk-8970 | Prodrug of raltegravir with enhanced colonic absorption |
|
| DCC3401 | Mkk3/6-in-6 | Novel potent and selective MKK3/6 inhibitor |
|
| DCC3402 | Mkp5-in-1 | Novel highly specific, potent, orally bioavailable MKP5 inhibitor |
|
| DCC3403 | Km04794 | Novel endoplasmic reticulum proteostasis modulator, enhancing insulin production in pancreatic β cells, inhibiting the UPR, alleviating ER stress and protein aggregation, improving intracellular insulin levels and insulin secretion |
|
| DCC3404 | ml312 | Novel Inhibitor of Scavenger Receptor BI-mediated Lipid Uptake |
|
| DCC3405 | Mlck Inhibitor Peptide-18 | Selective inhibitor of Myosin Light Chain Kinase (MLCK) |
|
| DCC3406 | Mln-0415 | Novel IKK2 inhibitor, decreasing NF-κB activation and down-regulating the expression of a number of inflammatory proteins |
|
| DCC3407 | Mln944 | Novel potent DNA binding agent, stabilizing topoisomerase-dependent cleavage, demonstrating exceptional efficacy against a number of murine and human tumor models |
|
| DCC3408 | Mln-977 | Second generation 5-LO inhibitor, blocking the production of leukotrienes |
|
| DCC3409 | Mls000099089 | Novel selective and potent inhibitor of recombinant h12/15-LOX and cellular mouse 12/15-LOX (m12/15-LOX) |
|
| DCC3410 | Mls000536924 | Potent and selective competitive inhibitor of human epithelial 15-lipoxygenase-2 (15-LOX-2) |
|
| DCC3411 | Mls000545091 | Potent and selective mixed-type inhibitor of human epithelial 15-lipoxygenase-2 (15-LOX-2) |
|
| DCC3412 | Mls000733230 | Novel potent inhibitor of EBOV infection |
|
| DCC3413 | Mls001158554 | Novel Inhibitor of Human Cytomegalovirus |
|
